Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alzheimer Disease, At Risk”

73 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 73 results

Not applicableNot Yet RecruitingNCT07364019
What this trial is testing

The Brain Health PRO Online Risk Factor Reduction Study to Prevent Dementia

Who this might be right for
Dementia PreventionSubjective Cognitive ImpairmentMild Cognitive Impairment+3 more
University of British Columbia 700
Not applicableNot Yet RecruitingNCT07212699
What this trial is testing

Development of an Outcome Score for Patients With Knee Osteoarthritis and Knee Joint Endoprosthesis Using an App

Who this might be right for
Knee OsteoarthritisKnee Arthroplasty
Technical University of Munich 450
Not applicableUnknownNCT02832921
What this trial is testing

Cognitive-motor Intervention Using Virtual Reality for Middle-aged Individuals at High Dementia Risk

Who this might be right for
Alzheimer's Disease (AD)
Sheba Medical Center 200
Testing effectiveness (Phase 2)Looking for participantsNCT05822362
What this trial is testing

CBD for Individuals at Risk for Alzheimer's Disease

Who this might be right for
Mild Cognitive Impairment
University of Colorado, Denver 236
Large-scale testing (Phase 3)Ended earlyNCT03131453
What this trial is testing

CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease

Who this might be right for
Alzheimers Disease
Novartis Pharmaceuticals 1,145
Testing effectiveness (Phase 2)Study completedNCT02702817
What this trial is testing

Randomized Trial of Low-dose Naproxen in Cognitively Intact Persons at Risk of Alzheimer's Dementia

Who this might be right for
Alzheimer DiseaseCognitive Decline Due to Alzheimer DiseaseMild Cognitive Impairment Due to Alzheimer Disease
Douglas Mental Health University Institute 200
Large-scale testing (Phase 3)Active Not RecruitingNCT06653153
What this trial is testing

Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)

Who this might be right for
Alzheimer's Disease
Eli Lilly and Company 1,400
Not applicableStudy completedNCT03717597
What this trial is testing

Nonrandomized Evaluation of a Multidimensional Behavioral Intervention

Who this might be right for
Subjective Cognitive Concerns (SCC)
University of California, Davis 15
Large-scale testing (Phase 3)Study completedNCT00236431
What this trial is testing

Evaluate the Efficacy and Safety of Galantamine in Patients With Mild Cognitive Impairment

Who this might be right for
DementiaAlzheimer Disease
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 1,063
Not applicableStudy completedNCT03884647
What this trial is testing

DELPHI in Subjects at Risk for Stroke and Dementia

Who this might be right for
StrokeHypertensionDiabete Mellitus+9 more
QuantalX Neuroscience 335
Not applicableUnknownNCT03035851
What this trial is testing

Aerobic Exercise for Older Adults at Increased Risk of Alzheimer's Disease and Related Dementias

Who this might be right for
Alzheimer DiseaseDementia
University of Calgary 264
Not applicableLooking for participantsNCT05597410
What this trial is testing

Shanghai At Risk for Alzheimer's Disease: a Cohort Study

Who this might be right for
Alzheimer DiseaseDementiaNeurodegenerative Diseases+2 more
Ruijin Hospital 3,418
Large-scale testing (Phase 3)Study completedNCT00236574
What this trial is testing

Evaluate the Efficacy and Safety of Galantamine in Patients With Mild Cognitive Impairment

Who this might be right for
DementiaAlzheimer Disease
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 974
Early research (Phase 1)Active Not RecruitingNCT06673069
What this trial is testing

Hero: A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics (PK) and Pharmacodynamics (PD) of ION269 in Participants With Down Syndrome (DS) at Risk for Alzheimer's Disease (AD)

Who this might be right for
Alzheimer DiseaseDown Syndrome
Ionis Pharmaceuticals, Inc. 1
Very early researchLooking for participantsNCT05138848
What this trial is testing

Time-in-bed Restriction in Older Adults With Sleep Difficulties With and Without Risk for Alzheimer's Disease

Who this might be right for
Alzheimer Disease, Late OnsetMild Cognitive ImpairmentSleep+2 more
University of Pittsburgh 116
Not applicableStudy completedNCT02963415
What this trial is testing

Concurrent Aerobic Exercise and Virtual Reality Cognitive Training

Who this might be right for
Preclinical Alzheimer's Disease
University of Minnesota 39
Not applicableLooking for participantsNCT05507905
What this trial is testing

Effects of Dance and Music Appreciation on Brain Health and Fitness in People at Risk for Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Wake Forest University Health Sciences 200
Not applicableLooking for participantsNCT05795634
What this trial is testing

Cognitive Vulnerability to Stress in Individuals at Risk for Alzheimer's Disease

Who this might be right for
Mild Cognitive ImpairmentAlzheimer Disease
Johns Hopkins University 240
Not applicableUnknownNCT05669495
What this trial is testing

ANNE Vital Sign System Remote Sleep Assessment

Who this might be right for
Alzheimer DiseaseDementiaMild Cognitive Impairment+1 more
Sunnybrook Health Sciences Centre 750
Testing effectiveness (Phase 2)UnknownNCT01811381
What this trial is testing

Curcumin and Yoga Therapy for Those at Risk for Alzheimer's Disease

Who this might be right for
Mild Cognitive Impairment
VA Office of Research and Development 80
Load More Results